With the deepening of research on the relationship between hyperuricemia and tumor, it is found that different immune cell subsets, cell surface receptors, and cytokines have significant effects on the pathogenesis of gout and tumor, and the relationship between hyperuricemia and tumor shows a complex trend. This evidence concerns the gene CD177 and gout.